临界性髋关节发育不良患者翻修髋关节镜的疗效及倾向匹配对照分析
本研究前瞻性纳入2009年8月至2017年11月接受翻修髋关节镜联合关节囊折叠术的患者,报告临界性发育不良组(LCEA 18°-25°)至少2年随访的患者报告结局(PRO),并与倾向匹配(1:3)的无发育不良对照组(LCEA 25°-40°)比较。结果显示两组所有PRO均较基线显著改善,mHHS的MCID达成率、VAS的MCID达成率及二次手术率相似,但对照组在HOS-SSS和NAHS的MCID达成率更高(P=.042和P=.025),临界组向髋关节置换转换率23.8% vs 对照组7.9%(P=.052),无统计学差异。
要点
- 临界性发育不良患者翻修髋关节镜后所有PRO显著改善,mHHS的MCID达成率70%。
- 与倾向匹配的无发育不良对照组相比,mHHS和VAS的MCID达成率及二次手术率相似。
- 对照组HOS-SSS和NAHS的MCID达成率更高(P=.042和P=.025),临界组向髋关节置换转换率有升高趋势(P=.052)。
核心结论
- 临界性发育不良患者翻修髋关节镜后至少2年随访所有PRO显著改善,多数结局与无发育不良对照组相似。
- 临界组向髋关节置换转换率23.8% vs 对照组7.9%(P=.052),二次翻修镜率19.0% vs 11.1%(P=.350),均无统计学差异但临界组有升高趋势。
- 对临界性发育不良患者行翻修髋关节镜手术应谨慎评估预后。
研究设计与样本
- 队列研究,证据等级3级。
- 前瞻性收集2009年8月至2017年11月数据,纳入翻修髋关节镜联合关节囊折叠术且有基线及至少2年随访PRO的患者。
- 排除Tönnis分级>1或既往髋关节疾病者。
- 临界发育不良组LCEA 18°-25°,对照组LCEA 25°-40°,按性别、年龄、BMI和随访时间1:3倾向匹配。
主要发现
- 22例临界发育不良髋(21例患者)完成至少2年随访,所有PRO较基线显著改善,mHHS的MCID达成率70%。
- 21例临界发育不良髋与63例对照髋匹配,平均LCEA分别为22.6±1.7°和32.0±5.0°。
- 两组所有PRO改善程度相似;对照组HOS-SSS和NAHS的MCID达成率更高(P=.042和P=.025)。
- 向髋关节置换转换率:对照组7.9%(n=5),临界组23.8%(n=5),P=.052。
- 二次翻修镜率:对照组11.1%(n=7),临界组19.0%(n=4),P=.350。
关键数值与推荐
- 临界性发育不良定义:LCEA 18°-25°;无发育不良对照:LCEA 25°-40°。
- 纳入标准:翻修髋关节镜联合关节囊折叠术,有基线及至少2年随访的mHHS、NAHS、HOS-SSS和VAS疼痛评分。
- 排除标准:Tönnis分级>1或既往髋关节疾病。
- 倾向匹配比例1:3,匹配因素为性别、年龄、BMI和随访时间。
临床怎么用
- 临界性发育不良患者翻修髋关节镜后可获得显著PRO改善,但应向患者说明二次手术风险可能高于无发育不良者。
- 术后评估应关注HOS-SSS和NAHS等功能评分,其MCID达成率可能低于无发育不良患者。
- 对临界性发育不良患者行翻修髋关节镜需个体化权衡,谨慎判断预后。
局限性
- 临界发育不良组样本量较小(22髋),可能影响统计效能。
- 向髋关节置换转换率的组间差异仅为趋势(P=.052),未达统计学显著性。
- 研究为单中心队列,随访时间至少2年,长期结局未报告。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hip arthroscopy in patients with borderline dysplasia continues to be surrounded by controversy. Even more controversial is the management of the failed hip arthroscopy in this population. There is a paucity of studies in contemporary literature regarding outcomes after arthroscopic revision surgery. PURPOSE: (1) To report minimum 2-year patient-reported outcome (PRO) scores in patients with borderline dysplasia who underwent revision hip arthroscopy and (2) to compare these PRO scores with those of a propensity-matched control group without dysplasia who underwent revision hip arthroscopy. STUDY DESIGN: Cohort study; Level of evidence, 3. METHODS: Data were prospectively collected between August 2009 and November 2017. Inclusion criteria were revision arthroscopic surgery, capsular plication, and baseline and minimum 2-year follow-up for the following PROs: modified Harris Hip Score (mHHS), Nonarthritic Hip Score (NAHS), Hip Outcome Score-Sports Specific Subscale (HOS-SSS), and visual analog scale (VAS) for pain. Patients with Tönnis grade >1 or previous hip conditions were excluded. Two groups were created: a study group with borderline dysplasia (lateral center-edge angle [LCEA], 18°-25°) and a control group without dysplasia (LCEA, 25°-40°). Groups were propensity-matched in a 1:3 ratio for sex, age, body mass index, and follow-up time. RESULTS: A total of 22 revision borderline dysplastic hips (21 patients) had a minimum 2-year follow-up during the study period. Patients in this group reported significant improvements for all PROs from baseline and achieved the minimal clinically important difference (MCID) for the mHHS at a rate of 70%. Moreover, 21 borderline dysplastic hips (21 patients) were matched to 63 control hips (63 patients). Mean LCEA for the study and control groups was 22.6 ± 1.7 and 32.0 ± 5.0, respectively. Both groups reported similar improvement in all PROs. The rate for achieving the MCID for the mHHS and VAS was similar between groups; however, the control group had higher rates of meeting the MCID for the HOS-SSS and NAHS (P = .042 and P = .025, respectively). The rates of conversion to hip arthroplasty were 7.9% (n = 5) in the control group and 23.8% (n = 5) in the borderline dysplasia propensity-matched group (P = .052). The rate of re-revision arthroscopy was 11.1% (n = 7) in the control group and 19.0% (n = 4) on the borderline dysplasia group (P = .350). CONCLUSION: After revision hip arthroscopy, significant improvement was obtained for all PROs in patients with borderline dysplasia at a minimum 2-year follow-up. Moreover, outcomes, patient satisfaction, the rate for achieving the MCID for the mHHS and VAS, and the rate for secondary surgery were similar to those of a propensity-matched control group without dysplasia. Nevertheless, there was a nonsignificant trend toward higher secondary procedures in the study group; therefore, arthroscopic revision surgery in the borderline patients should be approached with measured prognosis.
引用
- Maldonado DR, Kyin C, Shapira J, et al. Revision Hip Arthroscopy in the Borderline Dysplastic Population: Reporting Outcomes With Minimum 2-Year Follow-up, With a Subanalysis Against a Propensity-Matched Nondysplastic Control Group. Am J Sports Med. 2020. PMID: 33216619. doi:10.1177/0363546520969878
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。